According to Iovance Biotherapeutics 's latest financial reports the company's current revenue (TTM ) is NZ$0.45 Billion. an increase over the revenue in the year 2024 that were of NZ$0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.